Squarepoint’s Ovid Therapeutics OVID Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$72.9K Sell
221,126
-44,365
-17% -$14.6K ﹤0.01% 2558
2025
Q1
$82.8K Buy
+265,491
New +$82.8K ﹤0.01% 2557
2024
Q2
Sell
-68,343
Closed -$208K 2846
2024
Q1
$208K Buy
68,343
+56,962
+501% +$174K ﹤0.01% 2073
2023
Q4
$36.6K Buy
+11,381
New +$36.6K ﹤0.01% 2391
2023
Q2
Sell
-11,271
Closed -$29.1K 2710
2023
Q1
$29.1K Buy
+11,271
New +$29.1K ﹤0.01% 2154
2022
Q3
Sell
-10,543
Closed -$23K 2392
2022
Q2
$23K Buy
+10,543
New +$23K ﹤0.01% 2017
2021
Q3
Sell
-37,797
Closed -$148K 2609
2021
Q2
$148K Buy
+37,797
New +$148K ﹤0.01% 2332
2021
Q1
Sell
-70,987
Closed -$164K 2923
2020
Q4
$164K Sell
70,987
-69,731
-50% -$161K ﹤0.01% 2209
2020
Q3
$808K Buy
+140,718
New +$808K 0.01% 1049
2020
Q2
Sell
-11,553
Closed -$34K 2367
2020
Q1
$34K Sell
11,553
-14,476
-56% -$42.6K ﹤0.01% 1742
2019
Q4
$108K Buy
+26,029
New +$108K ﹤0.01% 2240
2018
Q3
Sell
-14,700
Closed -$115K 2151
2018
Q2
$115K Buy
+14,700
New +$115K ﹤0.01% 1630